News stories about Nu Skin Enterprises (NYSE:NUS) have been trending somewhat positive this week, Accern reports. The research firm rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Nu Skin Enterprises earned a news sentiment score of 0.07 on Accern’s scale. Accern also gave news coverage about the company an impact score of 46.101838750998 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:

Nu Skin Enterprises (NUS) traded up $2.10 during midday trading on Friday, hitting $69.97. 530,822 shares of the company’s stock were exchanged, compared to its average volume of 388,864. The company has a market capitalization of $3,800.00, a PE ratio of 25.63, a PEG ratio of 2.47 and a beta of 1.57. Nu Skin Enterprises has a 12-month low of $47.10 and a 12-month high of $70.27. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.44.

Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Wednesday, November 1st. The company reported $0.76 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.76. The firm had revenue of $563.70 million for the quarter, compared to analysts’ expectations of $562.70 million. Nu Skin Enterprises had a net margin of 6.97% and a return on equity of 22.38%. The company’s revenue was down 6.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.98 earnings per share. analysts expect that Nu Skin Enterprises will post 3.23 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, December 6th. Investors of record on Friday, November 17th were paid a $0.36 dividend. The ex-dividend date was Thursday, November 16th. This represents a $1.44 annualized dividend and a dividend yield of 2.06%. Nu Skin Enterprises’s dividend payout ratio is 52.75%.

NUS has been the subject of several research reports. Zacks Investment Research downgraded shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research report on Tuesday, October 17th. ValuEngine upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Tuesday, November 14th. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $62.00.

In related news, President Ryan S. Napierski sold 11,667 shares of the business’s stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $63.84, for a total value of $744,821.28. Following the sale, the president now owns 71,634 shares of the company’s stock, valued at $4,573,114.56. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, President Ryan S. Napierski sold 6,933 shares of the business’s stock in a transaction on Tuesday, October 10th. The shares were sold at an average price of $64.00, for a total transaction of $443,712.00. The disclosure for this sale can be found here. In the last three months, insiders sold 218,732 shares of company stock worth $14,599,287. 5.20% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY NOTICE: This story was first posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this story on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The correct version of this story can be accessed at

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Insider Buying and Selling by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with's FREE daily email newsletter.